Single-Use Bioprocessing Systems Displace Stainless Steel
Biopharma manufacturers increasingly specify single-use bioprocessing systems, including disposable bioreactor bags and pre-sterilized flow paths, over traditional stainless steel fermentation infrastructure that requires extensive cleaning validation between production campaigns for different biologic products. Equipment manufacturers report single-use systems now represent roughly 42% of new bioprocessing installations, a substantial increase from a decade ago when stainless steel systems dominated nearly all new facility construction almost universally. This shift is meaningfully reducing facility commissioning timelines while improving manufacturing flexibility for biopharma companies producing multiple biologic products. Manufacturers view this shift as essential to remaining competitive in a flexibility-driven category. A closely related view comes from the pharmaceutical autoclave machine market, which MMA projects to grow at a 7.2% CAGR to USD 1.85 billion by 2036.
Market Impact: Covers 3,000 plus biopharma facilit








